KELLY HARTNETT: Open Payments
NPI 1043617673 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,149 in 27 payments from 9 companies in 2025. Trend: 2023 $681 · 2024 $1,258 · 2025 $2,149
Food & beverage: $2,149
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $363 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $338 |
| Galderma Laboratories, L.P. | 3 | $280 |
| Organon LLC | 3 | $265 |
| Regeneron Healthcare Solutions, Inc. | 3 | $259 |
| Novartis Pharmaceuticals Corporation | 3 | $222 |
| UCB, Inc. | 2 | $165 |
| Janssen Biotech, Inc. | 3 | $149 |
| ABBVIE INC. | 2 | $107 |
Products named: DUPIXENT, NEMLUVIO, VTAMA, Bimzelx, TREMFYA, ILUMYA, COSENTYX, Winlevi.
Industry payments across OH — which companies pay providers there.
